Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Christine Obondo"'
Publikováno v:
Medicina, Vol 59, Iss 10, p 1727 (2023)
The magnetic technique using superparamagnetic nanoparticles of iron oxide has been well established for sentinel lymph node detection. Its main advantage is in the context of logistics, with the possibility to inject several weeks before surgery and
Externí odkaz:
https://doaj.org/article/c4db8b298a144f22921ef7d8022f6b04
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 17, Iss 6, Pp 400-405 (2011)
Background/Aim: A prospective longitudinal study was conducted to describe short-term outcome and quality of life (QOL) of endoscopically placed gastric balloon (EPGB) and laparoscopic adjustable gastric band (LAGB). Materials and Methods: Forty seve
Externí odkaz:
https://doaj.org/article/cfcff02789e64b98a974ed82419f5e2a
Autor:
Allan Jazrawi, Madeleine Wärnberg, Abdi-Fatah Hersi, Christine Obondo, Lida Pistioli, Staffan Eriksson, Andreas Karakatsanis, Fredrik Wärnberg
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 6017
Simple Summary Both superparamagnetic iron oxide nanoparticles (SPIO) and blue dye (BD) have been reported to cause skin staining after breast-conserving surgery. SPIO is a novel tracer that has been shown to identify sentinel lymph nodes (SLNs) in p
Autor:
Louise Magill, Juliette Murray, Alison Lannigan, Jennifer McIlhenny, Dermot Murphy, Christine Obondo, Jonathan Hicks, Sarah Slater, Tareq Abdullah, Martina Martinez, James Mansell
Publikováno v:
European Journal of Surgical Oncology. 47:e337
Autor:
José Pedro Gil, Christin Sisowath, Christine Obondo, Andreas Mårtensson, Anders Björkman, Johan Strömberg, Mwinyi I. Msellem
Publikováno v:
The Journal of infectious diseases. 191(6)
Artemisinin derivative-based combination therapy is expected to suppress the development of Plasmodium falciparum drug resistance in Africa. We have performed an artemether-lumefantrine (Coartem; Novartis) follow-up clinical trial in Zanzibar, in whi
Publikováno v:
European Journal of Surgical Oncology (EJSO). 35:1217-1218